Preventing resistance in cancer therapy

The latest developmental drugs, particularly for use in oncology, rely on the targeted degradation of harmful pathogenic proteins. In a recent study published in Nature Chemical Biology, researchers at CeMM, the Research ...

DNA 'nanotransporters' to treat cancer

A team of Canadian researchers from Université de Montréal has designed and validated a new class of drug transporters made of DNA that are 20,000 times smaller than a human hair and that could improve how cancers and other ...

Study investigates longer life due to faulty RNA processing

The control of RNA metabolism is crucial to the regulation of animal longevity, researchers from the Max Planck Institute for Biology of Aging in Cologne have now discovered. They found that worms live longer when certain ...

page 7 from 40